West Pharmaceutical Services Reports Q3 EPS Of $2.31.

WEST ANNOUNCES THIRD-QUARTER 2021 RESULTS AND DECLARES FOURTH-QUARTER 2021 DIVIDEND.
Q3 ADJUSTED EARNINGS PER SHARE $2.06.
Q3 EARNINGS PER SHARE $2.31.
SEES FY SALES $2.8 BILLION TO $2.81 BILLION.
Q3 SALES ROSE 28.9 PERCENT TO $706.5 MILLION.
RAISING FULL-YEAR 2021 ADJUSTED-DILUTED EPS GUIDANCE TO A NEW RANGE OF $8.40 TO $8.50.
WEST PHARMACEUTICAL SERVICES - APPROVED A FOURTH-QUARTER 2021 DIVIDEND OF $0.18 PER SHARE, A 5.9% INCREASE OVER $0.17 PER SHARE.
Q3 EARNINGS PER SHARE VIEW $1.80, REVENUE VIEW $687.1 MILLION -- REFINITIV IBES DATA.
FY2021 EARNINGS PER SHARE VIEW $8.21, REVENUE VIEW $2.80 BILLION -- REFINITIV IBES DATA.